Mealey's (February 28, 2018, 10:42 AM EST) -- PENSACOLA, Fla. — Abilify co-marketer Otsuka American Pharmaceutical Inc. (OAPI) on Feb. 22 told a Florida multidistrict litigation judge that it should not be sanctioned for discovery violations because it had no duty to preserve emails well before any litigation could have been anticipated (In Re: Abilify [Aripiprazole] Products Liability Litigation, MDL Docket No. 2734, No. 16-md-2734, N.D. Fla., Pensacola Div.)....